Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies
Top Cited Papers
Open Access
- 15 September 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (s3) , S147-S156
- https://doi.org/10.1086/321841
Abstract
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiotic-resistant mutants. The strategy is based on thKeywords
This publication has 39 references indexed in Scilit:
- Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998New England Journal of Medicine, 1999
- First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisonsThe Lancet, 1999
- Multidrug Resistance — A Sign of the TimesNew England Journal of Medicine, 1998
- Staphylococcus aureus: A Well–Armed PathogenClinical Infectious Diseases, 1998
- Fluoroquinolone Resistance Associated with Specific Gyrase Mutations in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1996
- Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory studyJournal of Antimicrobial Chemotherapy, 1996
- Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone familyPublished by American Medical Association (AMA) ,1996
- Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991Clinical Infectious Diseases, 1994
- The Emergence of Drug-Resistant Tuberculosis in New York CityNew England Journal of Medicine, 1993
- Development of resistance during antibiotic therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987